We are live on ! Find out more
BOUT icon

CapForce IBD Breakout Opportunities ETF

7 hedge funds and large institutions have $237K invested in CapForce IBD Breakout Opportunities ETF in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

5.36% less ownership

Funds ownership: 7.2%1.84% (-5.4%)

22% less funds holding

Funds holding: 97 (-2)

77% less capital invested

Capital invested by funds: $1.01M → $237K (-$773K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
+$64.2K
2
UBS Group
UBS Group
Switzerland
+$21.7K

BOUT Hedge Fund Activity: Q2 2023 in Review

7 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q2 2023, worth a combined $237K — down 77% from $1.01M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BOUT and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.

The largest buyer was Osaic Holdings, adding an estimated $64.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $851K sold.

  • 7 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q2 2023, down from 9 in Q1 2023.
  • Funds reported $237K of CapForce IBD Breakout Opportunities ETF stock for Q2 2023, down 77% quarter-over-quarter.
  • 0 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q2 2023 and 1 closed out, a net change of -1 holder.
  • The largest CapForce IBD Breakout Opportunities ETF buyer in Q2 2023 was Osaic Holdings, an estimated $64.2K added.
  • The largest CapForce IBD Breakout Opportunities ETF seller in Q2 2023 was Citadel Advisors, an estimated $851K sold.

Based on aggregated 13F filings for Q2 2023.